Tranexamic acidTranexamic acid (Gland Pharma Limited)
Welcome to the PulseAid listing for the Tranexamic acid drug offered from Gland Pharma Limited. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | Tranexamic acid |
SUBSTANCE NAME: | TRANEXAMIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-22 |
END MARKETING DATE: | 0000-00-00 |
Tranexamic acid Tranexamic acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Tranexamic acid Tranexamic acid from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2017-02-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-160_1b228f61-57fa-4fd5-b718-f6ffccfc3e30 |
PRODUCT NDC: | 68083-160 |
APPLICATION NUMBER: | ANDA207239 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers: